Your brand is a cornerstone of your prosperity—but a brand is only as strong as the team protecting it. You’ve built your brand, marks and reputation into fundamental assets. Count on the global intellectual property lawyers at Dentons to defend them.

Enact a comprehensive trademark acquisition, protection and policing strategy, supported by partners with extensive experience in the dense world of intellectual property law. Monitor these key assets vigilantly and react quickly to potential discrepancies or threats. Deploy the appropriate legal remedies when challenges arise. Maximize brand value through contractual and licensing arrangements. Maintain that value through rigorous enforcement.

As the expansion of digital markets magnifies the risks to intellectual property, Dentons works continuously to preserve your vital brand elements. Our expertise addresses every aspect of trademark strategy, including:

• Infringement, unfair competition and passing off
• Brand clearance advice
• Licensing and exploitation
• Strategic IP structuring
• Portfolio evaluation, prosecution (direct and through trusted relationships) and management
• Trade dress and brand due diligence
• Dilution
• Domain name registration and management, including combating cybersquatting
• Comparative advertising and legitimate fair use of third-party trademarks
• Investigation, computer forensics and e-Discovery lab
• Media and entertainment industry issues
• Customs seizures
• Anti-counterfeiting

Recognition

Dentons recognized in the 2019 edition of the World Trademark Review 1000 – The World’s Leading Trademark Professionals

February 8, 2019

World Trademark Review has published the 2019 edition of its WTR 1000 - The World’s Leading Trademark Professionals and 17 lawyers from Dentons’ global Intellectual Property and Technology group were recognized for their world-class legal trademark knowledge and experience. 

Dentons lawyers shine in The Legal 500 Hall of Fame

March 1, 2018

Dentons is proud to announce that 17 of our lawyers from Africa, Europe, Middle East and the United States have made it into The Legal 500 Hall of Fame, as lawyers at the pinnacle of the profession.

Dentons recognized by Best Lawyers in America in 200 categories

August 15, 2017

Dentons, the world's largest law firm, has been recognized by The Best Lawyers in America in 200 categories in the 2018 edition of the highly regarded publication. The ranking highlights 138 individual lawyers from Dentons, including nine who have been recognized for more than 25 years, 51 who have been listed for 10 years and 12 who were included for the first time.

View all recognition for Trademarks

Insights

Legal issues for Canadian construction business

November 15, 2019

In this newsletter, we provide a round-up of Dentons' recent articles on topics of interest to Canadian construction businesses.

Rise in medical cannabis trade marks in Australia

February 25, 2019

Legalising access to medical cannabis has had a flow on effect on the Australian Trade Marks Register with now more than 225 pending and registered trade marks claiming the term ‘cannabis.’

Brexit and brands: are you ready?

January 22, 2019

After last week's "meaningful" vote on Brexit, it seems that the future is even more uncertain. There is a serious risk that the UK could leave the EU at 11.00am on 29 March 2019 without a deal in place. Alternatively, Article 50 could be extended and the UK might then leave with a deal, and a little more order, later on. Or there could be a second referendum, the result of which is, of course, unknown.

View all insights for Trademarks

News and Events

Recent Press Releases

Dentons advises Bayer in the largest action against drug counterfeiters to date

May 19, 2015

Global law firm Dentons represented Bayer Healthcare under civil and criminal law in connection with the complex “Pillendienst” case. The defendants in this procedure, among them Matthias M., considered to be one of the founders of the “Pillendienst”, were accused of criminal trademark infringement, criminal offences under the Medicinal Products Act and conspiracy to defraud.